Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;162(2):676-683.
doi: 10.1002/ijgo.14722. Epub 2023 Mar 3.

Combined first trimester screening for trisomy 21: Assessment of excess risk in case of free ß-human chorionic gonadotrophin between 5 and 10 multiples of the median

Anthony Atallah  1   2 , Hélène Leport  3 , Corinne Sault  4 , Benoit De La Fournière  2   5 , Cyril Huissoud  1   2 , Marion Cortet  2   5
Affiliations

Combined first trimester screening for trisomy 21: Assessment of excess risk in case of free ß-human chorionic gonadotrophin between 5 and 10 multiples of the median

Anthony Atallah et al. Int J Gynaecol Obstet. 2023 Aug.

Abstract

Objective: The first trimester combined risk of trisomy 21 is obtained by multiplying the risk related to maternal age by the likelihood ratios of nuchal translucency, free beta-human chorionic gonadotrophin (β-hCG) and placenta associated plasma protein-A. Beyond five multiples of the median (MoM) of β-hCG, the risk of trisomy 21 is truncated. The objective of the present study was to evaluate the evolution of the first trimester combined risk of trisomy 21 in individuals with first-trimester free-β-hCG levels between 5 and 10 MoM.

Methods: We conducted a non-interventional cohort study from a 6-year database of combined first-trimester trisomy 21 screening of all individuals who underwent the screening in a French specialized medical analysis center. We included all pregnant individuals who had a serum-free β-hCG between 5 and 10 MoM. Patients for whom the status of the fetus, with or without trisomy 21, was not identified by the outcome of the pregnancy or by a karyotype result were excluded from the study. The discriminatory capacity of free-β-hCG above 5 MoM was studied by a receiver operating characteristic curve. We used an orthogonal polynomial regression to represent the evolution of likelihood ratios according to free-β-hCG in MoM.

Results: Among 413 216 combined first-trimester screens of trisomy 21, 2239 (0.5%) screens met the inclusion criteria. In the selected population, 801 (35.8%) were excluded from the study because of missing fetal or neonatal status, and 46 (3.2%) fetuses out of 1438 included were diagnosed with trisomy 21. For free β-hCG values between 5 and 10 MoM, the area under the curve is 0.56 (0.46-0.65). The scatterplot of the likelihood ratio of β-hCG showed an increasing parabolic pattern: the likelihood of trisomy 21 increases with the free-β-hCG threshold.

Conclusion: To override the truncated risk of trisomy 21 in case of free β-hCG values between 5 and 10 MoM, the study has allowed us to estimate the adjusted risk of trisomy 21, enabling health professionals to offer appropriate prenatal counseling.

Keywords: biomarkers; human chorionic gonadotrophin; pregnancy; prenatal; risk assessment; screening; trisomy 21.

PubMed Disclaimer

References

REFERENCES

    1. Muller F, Dreux S, Czerkiewicz I, et al. Down syndrome maternal serum screening: results' comments recommended by accredited biologists. J Gynecol Obstet Biol Reprod (Paris). 2014;43(9):671-679. doi:10.1016/j.jgyn.2014.05.012
    1. Spencer K, Enofe O, Cowans NJ, Stamatopoulou A. Is maternal renal disease a cause of elevated free β-hCG in first trimester aneuploidy screening? Prenat Diagn. 2009;29(11):1045-1049. doi:10.1002/pd.2347
    1. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-a. Ultrasound Obstet Gynecol. 1999;13(4):231-237. doi:10.1046/j.1469-0705.1999.13040231.x
    1. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31(1):7-15. doi:10.1002/pd.2637
    1. Barnes IM, Bestwick JP, Larsen SO. Setting truncation limits for marker values in medical screening. J Med Screen. 2007;14(2):103-106. doi:10.1258/096914107781261873

Substances

LinkOut - more resources